Examining the Effects of Float-REST for Recovery in Individuals With Chronic Lower Back Pain

Understanding Physiology of Float-REST and the Consequential Effects on Subjective and Objective Recovery in Individuals With Chronic Lower Back Pain

Researchers at the West Virginia University Rockefeller Neuroscience Institute are looking for volunteers to participate in a research study to evaluate what effects Float-REST (Restricted environmental Stimulation Technique) has on the stress response caused by chronic lower back pain.

Study Overview

• Status: Completed
• Conditions: Pain, Chronic
• Intervention / Treatment: Other: Float-REST; Other: Nappod

Detailed Description

Chronic lower back pain has a profound impact on a patient's life and body. These patients face a litany of internal and external stressors. These stressors cause a detrimental sustained activation of the endogenous stress response, which is mediated by the autonomic nervous system. Our central hypothesis is that this high stress load exacerbates the symptoms of chronic pain by causing changes in how the brain processes pain signals from the periphery. If researchers can better understand how stress plays a role in the mitigation of pain, then there may be improvements in patient's quality of life. Restricted Environmental Stimulation Therapy (REST) flotation has been identified as a possible alternative treatment to pharmacological intervention for several conditions like generalized anxiety disorder by helping to reduce stress. However, there have yet to be any investigation into what affects that REST flotation has in chronic lower back pain.

• Study Type: Interventional
• Enrollment (Actual): 24
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • West Virginia
    • Morgantown, West Virginia, United States, 26505
      • Rockefeller Neuroscience Institute at West Virginia University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 65 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Able and willing to give informed consent
• Right-hand dominant
• Naïve to mindfulness interventions (i.e. guided meditation, guided yoga, previous REST flotation)
• Have chronic lower back pain (at least 12 weeks since onset)
• Ability to enter/exit REST Flotation Tank unassisted
• Stable prescription medication (No changes in dose, start/stop within 30 days of the beginning of the study)

Exclusion Criteria:

• MRI incompatibility: The participant cannot have any non-MRI compatible metallic (magnetic) material in, on, or attached to their body.
• Current fear of small spaces or water
• Current balance problems or motion sickness
• Body width greater than 60cm
• Current contagious skin condition

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Basic Science
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Flotation-REST; Float-REST therapy uses sensory deprivation tanks that consist of a very large warm water enclosure with a high concentration of Epsom salt to create a completely buoyant environment. This, along with a combination of temperature that is kept equal to skin temperature (94 degrees), allows the participant to eliminate the gravitational effects on the body, and along with lack of sound and low to no light (depending on comfort) allows the brain and body to completely relax for augmented physical and mental recovery. The room will contain an intercom that allows participants to communicate with study personnel in the event the participant needs assistance. Participants will undergo 60 minute sessions twice a week for 3 weeks.	Other: Float-REST; Participants will utilize sensory deprivation tanks.
Placebo Comparator: Nappod; Participants in this arm will be asked to lie comfortably in a special recliner called a Metro Nappod for the duration of a 60 minute session twice a week for 3 weeks. The chair is located in a quiet and dimly lit room to minimize interruptions. The pod is equipped with a privacy visor, built-in speaker, and a timer with an alarm.	Other: Nappod; Participants will utilize nappod.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Changes in Functional Magnetic Resonance Imaging (fMRI)	fMRI analysis looks at alterations in brain activity from baseline at rest and in response to pain cues	Participants will undergo an fMRI session at the beginning (Week 1) to establish a baseline and a follow up end of the study (Week 8).

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Nocturnal Heart Rate as measured by OURA Ring	Heart rate (beats per minute) will be quantified throughout the night via the OURA ring.	Daily from baseline through study completion at 8 weeks
Change in daily self-report measures for task load	End of Day Questionnaire (EoD)-Developed at the Rockefeller Neuroscience Institute (RNI) as a modification of the NASA Task Load Index. There are 5 Likert scales to assess workload (0=very low and 100=very high), as well as 4 follow up questions. This questionnaire addresses subjective measures of workload and stressors that were encountered throughout the day.	Daily from baseline through study completion at 8 weeks
Change in per session self-report measures	State-Trait Anxiety Index (STAI) - Commonly used measure of state and trait anxiety, and done with 20 very brief questions. Values range from 20 to 80, with higher scores representing more severe anxiety. Participants will complete the STAI questionnaire before and after each session, twice a week.	Before and after each float session (Weeks 2-7)
Change in testing battery self-report measures in personality	Big Five Inventory (BFI)-44 item inventory designed to measure the Big Five Factors of personality on a 5-point Likert Scale. Higher scores indicate a higher tendency for that personality trait (1=disagree strongly to 5=agree strongly).	Beginning and end of the investigation (Week 1 & Week 8)
Change in testing battery self-report measures in emotional regulation	Emotion Regulation Questionnaire (ERQ)-10-item scale designed to measure tendency to regulate emotions. Each item is answered on a 7-point Likert Scale (1=strongly disagree to 7=strongly agree). Higher scores indicate a higher emotion regulation strategy.	Beginning and end of the investigation (Week 1 & Week 8)
Change in testing battery self-report measures in mindfulness	Five Facet Mindfulness Questionnaire (FFMQ)-39 item inventory assesses the five facets of mindfulness on a 5-point Likert Scale (1=never or very rarely true and 5=very often or always true). Each facet is tallied and the sum total responses are divided by 39 (number of items). Higher scores indicate higher levels of mindfulness.	Beginning and end of the investigation (Week 1 & Week 8)
Change in testing battery self-report measures in sleep quality	Pittsburgh Sleep Quality Index (PSQI)- 19 item inventory with 7 subjective components that assess sleep quality over time. Each component is scored from 0 to 3 (0=very good and 3=very bad). The sum of the components is the global score and ranges 0-21 (0=no difficulty and 21=severe difficulties). The higher the global score, the poorer the sleep quality.	Beginning and end of the investigation (Week 1 & Week 8)
Cold Pressor Stressor	The cold pressor is a water bath with its temperature maintained at 3C. The participant is asked to submerge a hand in the water bath. The water is cold enough to be a painful stimuli but not so cold as to cause tissue damage. The participant rates their pain level on a standard Wong-Baker pain scale prior and immediately after voluntary withdraw from the cold pressor. The Wong Baker pain scale asks the participant to rate their pain on a scale of 0-10 with 0= no pain and 10= the most pain. Duration of time spent in the water is also recorded.	The participant will undergo the cold pressor test at the beginning (Week 1) and end of the study (Week 8) with the option for an additional session after a few sessions at the investigators discretion.
Serum Analysis for changes in Interleukin 1B concentration	Blood samples will be collected through out the study and analyzed for a key stress indicators Interleukin 1B.	Beginning (Week 1), middle (Week 5), and end of the investigation (Week 8)
Serum Analysis for changes in Interleukin 6 concentration	Blood samples will be collected through out the study and analyzed for a key stress indicators Interleukin 6.	Beginning (Week 1), middle (Week 5), and end of the investigation (Week 8)
Serum Analysis for changes in Cortisol concentration	Blood samples will be collected through out the study and analyzed for a key stress indicator Cortisol.	Beginning (Week 1), middle (Week 5), and end of the investigation (Week 8)
Changes in Serum Analysis for changes in Dehydroepiandrosterone concentration	Blood samples will be collected through out the study and analyzed for a key stress indicator Dehydroepiandrosterone.	Beginning (Week 1), middle (Week 5), and end of the investigation (Week 8)

Collaborators and Investigators

• Sponsor: West Virginia University
• Investigators: Principal Investigator: Victor S Finomore, PhD, West Virginia University

Study record dates

Study Major Dates

• Study Start (Actual): February 24, 2022
• Primary Completion (Actual): January 1, 2023
• Study Completion (Actual): January 1, 2023

Study Registration Dates

• First Submitted: January 13, 2022
• First Submitted That Met QC Criteria: February 17, 2022
• First Posted (Actual): March 2, 2022

Study Record Updates

• Last Update Posted (Actual): July 21, 2023
• Last Update Submitted That Met QC Criteria: July 19, 2023
• Last Verified: May 1, 2023

More Information

Terms related to this study

• Keywords: fMRI; Sensory Deprivation Tank
• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Back Pain; Low Back Pain; Chronic Pain
• Other Study ID Numbers: 2010130921

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No